Company intelligence / Profile preview

Bromatech

Manno, Ticino, Switzerlandbromatech.it ↗

Ownership: Private
Development stage: Other

Overview

Bromatech has over 25 years of experience developing and commercializing targeted probiotic food supplements based on strain-specific lactic acid bacteria, vitamins, antioxidants, and essential fatty acids. Their products are designed to interact with the human microbiome to promote gut health. The company collaborates closely with healthcare professionals for product development and practical application[1][2][3][5].

Therapeutic areas: GastroenterologyImmunology
Modalities: Live biotherapeutic product therapyMicrobial therapyProbiotic supplement (as a subcategory of microbial therapy)
Industry: Food & Nutrition

Partnerships

Extensive network of doctors, pharmacists, nutritionists, nurses, complementary medicine therapists for R&D collaboration

Beyond the preview

Go deeper on Bromatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bromatech.

Explore the full profile